type here...

Health Care

Antitrust and Competition

Opening the Black Box: The Hidden Costs of Data-Driven Mergers in Health Care

Theodosia Stavroulaki
Vertical data-driven mergers between health insurers and drug suppliers may facilitate health insurers’ efforts to discriminate against vulnerable populations, leaving them without...
Read more
Antitrust and Competition

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Rena Conti, Fiona Scott Morton, Adam Kroetsch, Stephen Colvill, Mark Rosenberg
Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...
Read more
Antitrust and Competition

How the FTC Protected the Market Power of Pharmacy Benefit Managers

Stacy Mitchell, Zach Freed
Pharmacy Benefit Managers (PBMs) were established in the 1960s to control drug costs but have since morphed into one of the most...
Read more
Antitrust and Competition

What Is the Price of a Prescription Drug?

Robin Feldman
Due to lack of transparency and mystery rebates, which are considered trade secrets, figuring out the price of a prescription drug is...
Read more
Antitrust and Competition

Tech Isn’t the Only Sector Deserving of Antitrust Investigation

Alec Stapp
The House Judiciary Committee’s antitrust report was a missed opportunity. The 450-page report focused solely on digital markets. But what about antitrust...
Read more
Antitrust and Competition

“The Antitrust Doctrine We’ve Seen Over the Last 40 Years Simply Does Not Match the Lived Experience of People”

Asher Schechter
In an interview with ProMarket, investigative journalist David Dayen discusses the toll that monopoly power takes on the lives of ordinary Americans...
Read more
Coronavirus

Webinar: Covid-19 and the US Health Care System

ProMarket writers
Political Economy of Covid-19 Series: Watch a Stigler Center conversation between author, journalist, and former health insurance executive Wendell Potter and Chicago Booth...
Read more
Antitrust and the US Health Care System

“The Way Insurance Companies Have Rigged Our Health Care System, They’re Probably Going to Emerge as Financial Winners from This”

Asher Schechter
Author and former health insurance executive Wendell Potter explains to ProMarket why the employer-based health care system in the US is “collapsing” and why health...
Read more
Coronavirus

Option-Based Credit Spreads Signal a Recession, but the US Stimulus Will Soften the Blow

Mihir Gandhi, Pietro Veronesi
Over the past month, option-based credit spreads spiked and remain at elevated levels. The surge signals that a recession is at our door, but...
Read more
Coronavirus

The Case for Lockdown: in Italy’s Lombardy, It Can Reduce Covid-19 Potential Fatalities from 160,000 to 25,000

Carlo Favero
According to an analysis by Bocconi University professor Carlo Favero, the number of people infected with the coronavirus in Lombardy, Northern Italy, is 120,000, while...
Read more
1234Page 2 of 4

Latest news

Money in Politics

Healthcare Companies Spent More on Lobbying Than Any Other Industry Last Year

Brooke Fox
Threatened by regulated price caps from congress, the pharmaceutical industry spent nearly $390 million on lobbying in 2021 according to new data...
Read more
Antitrust and Competition

Antitrust and Rule by Judges

Paul Tucker
The early-1980s Posner-Stigler memorandum to incoming president Reagan’s transition team is interesting for a host of reasons, but most of all in...
Read more
Antitrust and Competition

Should the European Union Require Tech Firms to Adopt a Common Charger?

Federico Innocenti, Martin Peitz
According to a new European Commission directive expected to be approved in the next few months, tech firms will have to use...
Read more
News

Chart of the Week: Economists Don’t Think Congress Should Make Price Gouging Illegal

Brooke Fox
Most economists disagree with a new bill in the US that would set limits on "unconscionably excessive prices," according to a recent...
Read more
Antitrust and Competition

Neoliberal Economists Are Giving Biden Bad Advice on Inflation

Hal Singer
To spare the economy from the pain of further interest rate hikes, the President should aggressively pursue anticompetitive conduct by companies in...
Read more
Antitrust and Competition

How Would the Big Tech Self-Preferencing Bill Affect Users? 

Randy Picker
The Senate looks to be nearing a vote on the American Innovation and Choice Online Act, which would prohibit gatekeeping digital platforms...
Read more
News

New eBook Revisits George Stigler’s Theory of Regulatory Capture 50 Years Later

Filippo Lancieri, Luigi Zingales
To mark the 50-year anniversary of George Stigler’s seminal piece, “The Theory of Economic Regulation” we are publishing a new eBook examining...
Read more
View All

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.

About Us

Categories

What we are readingAntitrust and CompetitionNewsRegulatory CaptureMediaRent seeking